The Latest Breaking News from Citigroup

Citigroup has decided to maintain its Buy rating of Autodesk (NASDAQ:ADSK) and lower its price target from $286.00 to $264.00. Shares of Autodesk are trading down 1.6% over the last 24 hours, at $190.62 per share. A move to $264.00 would account for a 38.5% increase from the current share…

Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

The Dow Jones rose as Fed Chair Powell issued an inflation pledge. Twitter gained as the Elon Musk takeover took a twist. A Warren Buffett stock soared.

Someone with a lot of money to spend has taken a bearish stance on Citigroup (NYSE:C). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Berkshire Hathaway Inc (NYSE: BRK-B) bought $3 billion worth of shares in Citigroup Inc (NYSE: C) in Q1, giving the group a stake of about 2.8%, according to filings with regulators. 

Stock futures higher as growth concerns ease, dollar retreats; Consumer in focus with retail sales, Walmart earnings on tap; Twitter Tumbles as Musk demands proof on bot tally to keep takeover alive; Take-Two jumps as investors bet Zynga will offset muted outlook and Citigroup gets Buffett boost, but Verizon slumps…

The shares of the renowned megabank Citigroup (C) have slumped more than 20% in price this year. Furthermore, with geopolitical issues taking a toll on the global economy and Wall Street seeing a risk of default by major banks, is C a smart investment now? Read on.

Upgrades

Citigroup has decided to maintain its Buy rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) and lower its price target from $150.00 to $146.00. Shares of Ultragenyx Pharmaceutical are trading up 2.9% over the last 24 hours, at $53.30 per share.